申请人:E-THERAPEUTICS PLC
公开号:US10961238B2
公开(公告)日:2021-03-30
There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD).
所述的式 (I) 化合物可作为药物用于治疗涉及刺猬通路异常激活和/或功能失调的疾病,如癌症、纤维化和慢性移植物抗宿主病 (cGVHD)。